The Asian Pacific Journal of Cancer Prevention is a biweekly peer-reviewed open access medical journal covering oncology. It was established in and is published by the Asian Pacific Organization for Cancer Prevention , of which it is the official journal. It is also the official journal of the International Association of Cancer Registries. From Wikipedia, the free encyclopedia. Asian Pacific Organization for Cancer Prevention.
Asian Pacific Journal of Cancer Prevention (APJCP)
Asian Pacific Journal of Cancer Prevention and Challenges Facing in its 18th Year of Publishing
The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 green comprises the quarter of the journals with the highest values, Q2 yellow the second highest values, Q3 orange the third highest values and Q4 red the lowest values. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year.
Asian Pacific Journal of Cancer Prevention (APJCP) - Indexing and Abstracting
General Information. Required information, files and formatting guidelines. Privacy Statement.
As the APJCP steps in its 18th year of serving cancer scientists in Asia and Pacific region, the need to look back and examine past strategies is a must. After going through lows of losing Expanded Science Citation status Moore, and reaching to the verge of losing PubMed listing Mosavi Jarrahi, , the journal is now in a stable situation to plan for its future. This figure was higher than the median H-index for all cancer-related journals median